AGP Executive Report
Last update: 7 hours agoAir Safety & Drug Testing: ALPA India urged DGCA to protect confidentiality and procedural integrity in psychoactive substance testing, warning that “non-negative” screening results aren’t proof of drug abuse and can be triggered by OTC medicines and dietary factors, after an Air India turbulence case. Public Health & Respiratory Care: Zydus launched REVAHALE™, India’s first once-daily nebulised LAMA for COPD, aiming to help patients who struggle with inhaler technique. Healthcare Business: Yatharth Hospitals posted record Q1 FY27 results with 51% YoY revenue growth to ₹392.7 crore and announced a maiden interim dividend; Lilavati Hospital plans to add ~5,000 beds and open its first Kazakhstan super-speciality OPD in September. Infectious Disease Watch: Ulhasnagar reported 30 suspected dengue cases, prompting intensified monsoon measures; a study highlights why Candida auris can persist in hair follicles, complicating clearance. Medicines & Enforcement: DRI busted an illegal Tramadol unit in Maharashtra and foiled a Nigeria export bid, seizing 2 lakh tablets and arresting three. Policy & Access: India expanded its e-Visa entry network to 88 ports with 11 new entry points. Local Health & Emergencies: Mumbai police saved a man after a suicide attempt; a stabbing in Malad East left a woman dead and her husband fled. Road Safety: Nitin Gadkari said road accidents kill 1.8 lakh people annually, with 66% victims young.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.